We’re rated Excellent
4.7 out of 5 based on 100 reviews

Slovenian Monsoon Season Reading Sept 17

New private venture tackles the riddle of Long Covid—and aims to test treatments quickly

Initiative focuses first on hypothesis that coronavirus lingers in patients

New private venture tackles the riddle of Long Covid—and aims to test treatments quickly | Science | AAAS

I took an international trip with my frozen eggs to learn about the fertility industry

More people like me are using the services of specialized couriers to access reproductive care that isn’t available or affordable at home.

What it's like to fly frozen sperm, eggs, and stem cells around the world | MIT Technology Review

ESMO: BioNTech's CAR-T response rate falls in fresh cut of early-phase data

BioNTech's CAR-T response rate falls in updated early-phase data (fiercebiotech.com)

Verily raises $1bn to push ahead with precision health plans

Verily raises $1bn to push ahead with precision health plans - (pharmaphorum.com)

Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma

Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma | Nature Medicine

Forge Biologics continues its hot streak with $90M round to boost gene therapy manufacturing services

Forge Biologics continues its hot streak with $90M round to boost gene therapy manufacturing services – Endpoints News (endpts.com)

Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis

Akero hits fibrosis primary endpoint in midphase NASH trial (fiercebiotech.com)

Europe’s Drought Might Force Acceptance of Gene-Edited Crops

For decades, the EU has had some of the tightest restrictions on genetically altered agriculture. That could be about to change.

Europe’s Drought Might Force Acceptance of Gene-Edited Crops | WIRED

Ori Biotech taps MD Anderson, National Resilience joint venture to put its automated cell & gene therapy manufacturing tech to the test

Ori is courting big-name clients with its production tech (fiercepharma.com)

Treatment of Genetic Diseases With CRISPR Genome Editing

Treatment of Genetic Diseases With CRISPR Genome Editing | Genetics and Genomics | JAMA | JAMA Network

Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches

Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches | Dementia and Cognitive Impairment | JAMA | JAMA Network

SparingVision raises €75m for eye disease gene therapies

SparingVision raises €75m for eye disease gene therapies - (pharmaphorum.com)

Starry syndicate powers $165M bet on in vivo CAR-T therapies, enabling Penn spinout Capstan to set sail

Starry syndicate powers $165M bet on in vivo CAR-T therapies (fiercebiotech.com)

Prostate cancer – Nature Outlook

There is no malignancy more common for a man in a high-income country than prostate cancer.

Prostate cancer (nature.com)

Could immunotherapy finally breakthrough in prostate cancer?

Despite success against other cancers, prostate tumours have so far resisted treatment with immunotherapy. But some researchers are persisting with the approach.

Could immunotherapy finally breakthrough in prostate cancer? (nature.com)

‘Practice Changing’ Data Show Benefits of Cell Therapy in Advanced Melanoma

‘Practice Changing’ Data Show Benefits of Cell Therapy in Advanced Melanoma | Inside Precision Medicine

One of Long COVID’s Worst Symptoms Is Also Its Most Misunderstood

Brain fog isn’t like a hangover or depression. It’s a disorder of executive function that makes basic cognitive tasks absurdly hard.

What Makes Brain Fog So Unforgiving - The Atlantic

Borrowing CAR-T tool from cancer therapy, lupus patients go into remission

Lupus patients go into remission borrowing CAR-T cancer therapy - STAT (statnews.com)

Scientists are using AI to dream up revolutionary new proteins

Huge advances in artificial intelligence mean researchers can design completely original molecules in seconds instead of months.

Scientists are using AI to dream up revolutionary new proteins (nature.com)

Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential

Intellia's 2 gene editing therapies both see early successes (fiercebiotech.com)